APA (7th ed.) Citation

AC, H., AF, F., E, P., A, K., C, P., I, C., . . . A, A. (2022). Doxycycline inhibits the progression of metastases in early-stage osteosarcoma by downregulating the expression of MMPs, VEGF and ezrin at primary sites. Cancer treatment and research communications, 32, 100617. https://doi.org/10.1016/j.ctarc.2022.100617

Chicago Style (17th ed.) Citation

AC, Hadjimichael, et al. "Doxycycline Inhibits the Progression of Metastases in Early-stage Osteosarcoma by Downregulating the Expression of MMPs, VEGF and Ezrin at Primary Sites." Cancer Treatment and Research Communications 32 (2022): 100617. https://doi.org/10.1016/j.ctarc.2022.100617.

MLA (9th ed.) Citation

AC, Hadjimichael, et al. "Doxycycline Inhibits the Progression of Metastases in Early-stage Osteosarcoma by Downregulating the Expression of MMPs, VEGF and Ezrin at Primary Sites." Cancer Treatment and Research Communications, vol. 32, 2022, p. 100617, https://doi.org/10.1016/j.ctarc.2022.100617.